These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37337210)

  • 1. Aiding empirical research on the commercial determinants of health: a scoping review of datasets and methods about lobbying.
    Lacy-Nichols J; Quinn M; Cullerton K
    Health Res Policy Syst; 2023 Jun; 21(1):56. PubMed ID: 37337210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial lobbying and political contributions: an Australian scoping review.
    Lacy-Nichols J; Johnson M; Cullerton K
    Aust N Z J Public Health; 2023 Aug; 47(4):100073. PubMed ID: 37478519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposal for systematic monitoring of the commercial determinants of health: a pilot study assessing the feasibility of monitoring lobbying and political donations in Australia.
    Lacy-Nichols J; Cullerton K
    Global Health; 2023 Jan; 19(1):2. PubMed ID: 36611039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.
    Lacy-Nichols J; Christie S; Cullerton K
    Health Promot Int; 2023 Oct; 38(5):. PubMed ID: 37864804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Lobbying Footprint of Harmful Industries: 23 Years of Data From OpenSecrets.
    Chung H; Cullerton K; Lacy-Nichols J
    Milbank Q; 2024 Mar; 102(1):212-232. PubMed ID: 38219274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A framework of NGO inside and outside strategies in the commercial determinants of health: findings from a narrative review.
    Townsend B; Johnson TD; Ralston R; Cullerton K; Martin J; Collin J; Baum F; Arnanz L; Holmes R; Friel S
    Global Health; 2023 Oct; 19(1):74. PubMed ID: 37817196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposed approach to systematically identify and monitor the corporate political activity of the food industry with respect to public health using publicly available information.
    Mialon M; Swinburn B; Sacks G
    Obes Rev; 2015 Jul; 16(7):519-30. PubMed ID: 25988272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing.
    McCambridge J; Hawkins B; Holden C
    Addiction; 2014 Feb; 109(2):199-205. PubMed ID: 24261642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advocacy counterstrategies to tobacco industry interference in policymaking: a scoping review of peer-reviewed literature.
    Matthes BK; Kumar P; Dance S; Hird T; Carriedo Lutzenkirchen A; Gilmore AB
    Global Health; 2023 Jun; 19(1):42. PubMed ID: 37344818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "The architecture of the state was transformed in favour of the interests of companies": corporate political activity of the food industry in Colombia.
    Mialon M; Gaitan Charry DA; Cediel G; Crosbie E; Baeza Scagliusi F; Pérez Tamayo EM
    Global Health; 2020 Oct; 16(1):97. PubMed ID: 33046110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distilling the distillers: examining the political activities of the Distilled Spirits Council of the United States.
    Lesch M; McCambridge J
    Global Health; 2023 Mar; 19(1):22. PubMed ID: 36991443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the corporate political activity of major food industry actors in Fiji.
    Mialon M; Swinburn B; Wate J; Tukana I; Sacks G
    Global Health; 2016 May; 12(1):18. PubMed ID: 27160250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public opinion of alcohol industry corporate political activities.
    Miller P; Martino F; Robertson N; Stafford J; Daube M
    Aust N Z J Public Health; 2021 Jun; 45(3):283-289. PubMed ID: 34028934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate political activity of the dairy industry in France: an analysis of publicly available information.
    Mialon M; Mialon J
    Public Health Nutr; 2017 Sep; 20(13):2432-2439. PubMed ID: 28689497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.
    Watts C; Jones M; Lindorff K; Freeman B
    Public Health Res Pract; 2023 Dec; 33(4):. PubMed ID: 37164761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic Advocacy: Opportunities to Influence Health and Science Policy Under U.S. Lobbying Law.
    Fernandez Lynch H; Bateman-House A; Rivera SM
    Acad Med; 2020 Jan; 95(1):44-51. PubMed ID: 31599758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing power and politics in health policies and systems.
    Gore R; Parker R
    Glob Public Health; 2019 Apr; 14(4):481-488. PubMed ID: 30773135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing our understanding of the commercial determinants of health: Theories, methods, and insights from political science.
    Gómez EJ
    Soc Sci Med; 2022 May; 301():114931. PubMed ID: 35358943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada's Healthy Eating Strategy.
    Gaucher-Holm A; Mulligan C; L'Abbé MR; Potvin Kent M; Vanderlee L
    Global Health; 2022 May; 18(1):54. PubMed ID: 35619107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.